Hester Biosciences Ltd.
Snapshot View

2030.00 +11.25 ▲0.6%

06 October 2022, 04:01:00 PM
Volume: 141

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hester.in
Market Cap 1,726.89 Cr.
Enterprise Value(EV) 1,924.26 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 36.20 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 56.07 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 307.96 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.59 Calculated using Price: 2,030.00
Dividend Yield 0.49 Period Ending 2022-03
No. of Shares Subscribed 0.85 Cr. 8,506,865 Shares
FaceValue 10
Company Profile
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.56%
1 Week
+1.24%
1 Month
-4.02%
3 Month
-7.91%
6 Month
-25.39%
1 Year
-19.23%
2 Year
+9.25%
5 Year
+91.12%
10 Year
+2229.32%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.88 16.73 20.56 20.38 17.57 25.59 16.38 16.16 16.00
Return on Capital Employed (%) 17.78 17.26 18.98 19.75 20.20 26.64 16.53 17.33 14.02
Return on Assets (%) 6.89 8.84 11.08 11.43 10.10 14.97 9.04 8.70 8.03

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 67 75 85 102 122 141 177 201 228 260
Non Curr. Liab. 16 20 38 41 48 44 70 97 114 198
Curr. Liab. 39 45 35 38 38 55 49 83 61 97
Minority Int. 1 1 3 5 5 4 4 5 8 7
Equity & Liab. 124 142 160 186 213 244 299 387 411 562
Non Curr. Assets 74 85 100 112 133 146 158 227 250 367
Curr. Assets 50 57 60 74 80 98 142 159 162 195
Misc. Exp. not W/O
Total Assets 124 142 160 186 213 244 299 387 411 562

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 69 90 101 123 136 178 183 214 235 226
Other Income 1 0 1 0 3 7 6 5 14 15
Total Income 70 90 102 124 138 185 190 219 249 240
Total Expenditure -45 -65 -68 -82 -89 -110 -128 -146 -175 -175
PBIDT 25 26 34 41 50 75 62 73 74 65
Interest -6 -5 -4 -4 -4 -7 -7 -7 -4 -5
Depreciation -5 -6 -6 -7 -10 -12 -13 -13 -17 -18
Taxation -4 -5 -6 -8 -13 -16 -10 -15 -14 -12
Exceptional Items 3 -3
PAT 9 13 19 23 23 41 31 35 39 30
Minority Interest 0 0 0 1 3 1 -2 0 0 -1
Share Associate 0 2
Other Related Items
Consolidated Net Profit 9 14 19 24 26 42 29 34 39 31
Adjusted EPS 11 16 23 28 30 49 34 40 46 36

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 9 20 19 35 38 47 37 58 9
Cash Fr. Inv. -23 -15 -21 -13 -30 -26 -22 -74 -38 -117
Cash Fr. Finan. 10 7 7 -7 2 -11 3 19 -18 112
Net Change -1 2 5 -1 6 1 28 -19 1 4
Cash & Cash Eqvt 2 4 6 5 11 12 41 24 21 25

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73
Public 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of Trading Window
Closure of Trading Window
Sun, 25 Sep 2022
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We attach a press release by the Company titled Adequate supply of Goat Pox Vaccine by Hester in India to Immunize cattle against Lumpy Skin disease for your information and dissemination on your website.
Tue, 23 Aug 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Conference Call

Technical Scans View Details >>

Tue, 04 Oct 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 6 Months High Decrease 6 Months
CCI Bullish CCI Bullish
William %R Bullish William %R Bullish
Mon, 03 Oct 2022
High Delivery Percentage High Delivery Percentage

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.00 +1.2%
Divi's Laboratories Ltd. 99,171.10 3,735.70 -1.2%
Cipla Ltd. 91,534.16 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 54,354.34 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,831.42 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On Hester Biosciences Ltd.

What is Hester Biosciences share price?

Can I buy Hester Biosciences shares now?

What is the Dividend Yield of Hester Biosciences?

What is the Market Cap of Hester Biosciences?

What are the key metrics to analyse Hester Biosciences?

What is the 52 Week High and Low of Hester Biosciences?

What is the trend of Hester Biosciences share price?